Remibrutinib Shows Positive Effects on Sleep, Daily Activities for CSU Patients
Remibrutinib’s impact on sleep deprivation and daily activities for patients with chronic spontaneous urticaria (CSU) were highlighted in a presentation at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida.
Robert Snyder, MD, FAAD, presented “Effect of Remibrutinib on...